
|Videos|November 24, 2020
Ofatumumab vs Teriflunomide: Phase 3 ASCLEPIOS I/II Open-Label Extension Study
Advertisement
Episodes in this series

Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Evaluating Combined Supraorbital and Occipital Neuromodulation in Phase 3 Trial for Resistant Migraine: The RECLAIM Study
2
AI in MS: IJMSC Survey Results
3
NeurologyLive® Friday 5 — October 31, 2025
4
Episode 153: Overviewing the 2025 Alzheimer's Association's Blood-Based Biomarker Guidelines
5














































